Athos Therapeutics
PrivateLast Round
Seed Round
May 15, 2026
Total Funding Raised
$54.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Athos Therapeutics is a biotechnology company that develops an artificial intelligence technology platform and therapeutics aimed at patients with inflammatory bowel and autoimmune diseases, utilizing machine learning to discover and develop personalized drug and gene targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Athos Therapeutics Comparables
Compare Athos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Auransa | 82% | |
| Omic.ai | 79% | |
| Genesis Molecular AI | 79% | |
Athos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 15, 2026 | ||||
| Series B | Feb 16, 2024 | ||||
| Series A | Nov 15, 2021 | ||||
| Seed | Mar 1, 2020 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Raised $10.3M in a seed funding round.
- Mar 10, 2026
CEO to speak at The Montgomery Summit on March 10-11, 2026.
Athos Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Athos Therapeutics's valuation, stock price, and market status.